全球医用大麻行业领导者Tilray宣布,将在其位于德国的先进欧盟GMP认证工厂扩大优质精品大麻的生产规模。同时,Tilray Medical通过推出新的以患者为中心的产品,进一步丰富了Tilray精品大麻产品组合。
此次扩产计划体现了Tilray对欧洲医用大麻市场的持续投资和承诺,旨在为患者提供更高质量的医用大麻产品和服务。
全球医用大麻行业领导者Tilray宣布,将在其位于德国的先进欧盟GMP认证工厂扩大优质精品大麻的生产规模。同时,Tilray Medical通过推出新的以患者为中心的产品,进一步丰富了Tilray精品大麻产品组合。
此次扩产计划体现了Tilray对欧洲医用大麻市场的持续投资和承诺,旨在为患者提供更高质量的医用大麻产品和服务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.